Unapproved Drugs-Compliance Policy Guide, Sec. 440.100 Marketed New Drugs Without Approved NDAs or ANDAs

January 28, 2017 | Author: FDA Lawyers Blog | Category: N/A


Description

Download Unapproved Drugs-Compliance Policy Guide, Sec. 440.100 Marketed New Drugs Without Approved NDAs or ANDAs

Comments

SUPPORT DOCURI